Patients with Obesity Have Better Long-Term Outcomes after Hospitalization for COPD Exacerbation

References

• Putcha N, Drummond MB, Wise RA, et al. Comorbidities and chronic obstructive pulmonary disease: prevalence, influence on outcomes, and management. Semin Respir Crit Care Med. 2015;36(4):575–591. doi:10.1055/s-0035-1556063.
   PubMed Web of Science ®Google Scholar
• Rodriguez DA, Garcia-Aymerich J, Valera JL, et al. Determinants of exercise capacity in obese and non-obese COPD patients. Respir Med. 2014;108(5):745–751. doi:10.1016/j.rmed.2014.02.004.
   PubMed Web of Science ®Google Scholar
• Garcia-Rio F, Soriano JB, Miravitlles M, et al. Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease. PLoS One. 2014;9(8):e105220. doi:10.1371/journal.pone.0105220.
   PubMed Web of Science ®Google Scholar
• Ogden CL, Carroll MD, Kit BK, et al. Prevalence of childhood and adult obesity in the United States, 2011–2012. JAMA. 2014;311(8):806–814. doi:10.1001/jama.2014.732.
   PubMed Web of Science ®Google Scholar
• Davos CH, Doehner W, Rauchhaus M, et al. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail. 2003;9(1):29–35. doi:10.1054/jcaf.2003.4.
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Abbott KC, Salahudeen AK, et al. Survival advantages of obesity in dialysis patients. Am J Clin Nutr. 2005;81(3):543–554. doi:10.1093/ajcn/81.3.543.
   PubMed Web of Science ®Google Scholar
• Dimov D, Tacheva T, Koychev A, et al. Obesity in Bulgarian patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2013;10(4):215–222. doi:10.1177/1479972313504940.
   PubMed Web of Science ®Google Scholar
• Naderi N, Kleine CE, Park C, et al. Obesity paradox in advanced kidney disease: from bedside to the bench. Prog Cardiovasc Dis. 2018;61(2):168–181. doi:10.1016/j.pcad.2018.07.001.
   PubMed Web of Science ®Google Scholar
• Goto T, Hirayama A, Faridi MK, et al. Obesity and severity of acute exacerbation of chronic obstructive pulmonary disease. Ann ATS. 2018;15(2):184–191. doi:10.1513/AnnalsATS.201706-485OC.
   Google Scholar
• Lainscak M, von Haehling S, Doehner W, et al. Body mass index and prognosis in patients hospitalized with acute exacerbation of chronic obstructive pulmonary disease. J Cachexia Sarcopenia Muscle. 2011;2(2):81–86. doi:10.1007/s13539-011-0023-9.
   PubMed Web of Science ®Google Scholar
• Chittal P, Babu AS, Lavie CJ. Obesity paradox: does fat alter outcomes in chronic obstructive pulmonary disease? COPD. 2015;12(1):14–18. doi:10.3109/15412555.2014.915934.
   PubMedGoogle Scholar
• Yamauchi Y, Hasegawa W, Yasunaga H, et al. Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan. Int J Chron Obstruct Pulmon Dis. 2014;9:1337–1346.
   PubMed Web of Science ®Google Scholar
• Ramirez J, Peyrani P, Wiemken T, et al. A randomized study evaluating the effectiveness of oseltamivir initiated at the time of hospital admission in adults hospitalized with influenza-associated lower respiratory tract infections. Clin Infect Dis. 2018;67(5):736–742. doi:10.1093/cid/ciy163.
   PubMed Web of Science ®Google Scholar
• Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi:10.1056/NEJMoa021322.
   PubMed Web of Science ®Google Scholar
• Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(6):809–813. doi:10.1164/rccm.2107031.
   PubMed Web of Science ®Google Scholar
• Keller K, Hobohm L, Munzel T, et al. Survival benefit of obese patients with pulmonary embolism. Mayo Clin Proc. 2019;94(10):1960–1973. doi:10.1016/j.mayocp.2019.04.035.
   PubMed Web of Science ®Google Scholar
• von Haehling S, Anker MS, Anker SD. Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016. J Cachexia Sarcopenia Muscle. 2016;7(5):507–509. doi:10.1002/jcsm.12167.
   PubMed Web of Science ®Google Scholar
• Carbone S, Canada JM, Billingsley HE, et al. Obesity paradox in cardiovascular disease: where do we stand? Vasc Health Risk Manag. 2019;15:89–100. doi:10.2147/VHRM.S168946.
   PubMed Web of Science ®Google Scholar
• Elagizi A, Kachur S, Lavie CJ, et al. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2018;61(2):142–150. doi:10.1016/j.pcad.2018.07.003.
   PubMed Web of Science ®Google Scholar
• Lavie CJ, McAuley PA, Church TS, et al. Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol. 2014;63(14):1345–1354. doi:10.1016/j.jacc.2014.01.022.
   PubMed Web of Science ®Google Scholar
• Delgado C, Chertow GM, Kaysen GA, et al. Associations of body mass index and body fat with markers of inflammation and nutrition among patients receiving hemodialysis. Am J Kidney Dis. 2017;70(6):817–825. doi:10.1053/j.ajkd.2017.06.028.
   PubMed Web of Science ®Google Scholar
• Antonopoulos AS, Tousoulis D. The molecular mechanisms of obesity paradox. Cardiovasc Res. 2017;113(9):1074–1086. doi:10.1093/cvr/cvx106.
   PubMed Web of Science ®Google Scholar
• Barbarito N, De Mattia E. Grading the severity of obstruction in patients with chronic obstructive pulmonary disease and morbid obesity. Monaldi Arch Chest Dis. 2013;79(3–4):121–127. doi:10.4081/monaldi.2013.5210.
   PubMedGoogle Scholar
• Collins BF, Feemster LC, Rinne ST, et al. Factors predictive of airflow obstruction among veterans with presumed empirical diagnosis and treatment of COPD. Chest. 2015;147(2):369–376. doi:10.1378/chest.14-0672.
   PubMed Web of Science ®Google Scholar
• Quan H, Li B, Saunders LD, et al. Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res. 2008;43(4):1424–1441. doi:10.1111/j.1475-6773.2007.00822.x.
   PubMed Web of Science ®Google Scholar